ArticleFrontiers in immunology2021

Effectiveness of Regdanvimab Treatment in High-Risk COVID-19 Patients to Prevent Progression to Severe Disease.

Ji Yeon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.